AGL 38.56 Decreased By ▼ -0.77 (-1.96%)
AIRLINK 207.77 Increased By ▲ 17.83 (9.39%)
BOP 10.06 Increased By ▲ 0.55 (5.78%)
CNERGY 7.08 Decreased By ▼ -0.04 (-0.56%)
DCL 9.99 Decreased By ▼ -0.23 (-2.25%)
DFML 41.14 Decreased By ▼ -0.54 (-1.3%)
DGKC 103.46 Decreased By ▼ -6.36 (-5.79%)
FCCL 36.35 Decreased By ▼ -1.81 (-4.74%)
FFBL 91.59 Decreased By ▼ -4.67 (-4.85%)
FFL 14.60 Decreased By ▼ -0.29 (-1.95%)
HUBC 139.43 Increased By ▲ 10.60 (8.23%)
HUMNL 14.10 Decreased By ▼ -0.42 (-2.89%)
KEL 5.97 Decreased By ▼ -0.22 (-3.55%)
KOSM 7.86 Decreased By ▼ -0.13 (-1.63%)
MLCF 47.28 Decreased By ▼ -2.70 (-5.4%)
NBP 73.76 Increased By ▲ 1.33 (1.84%)
OGDC 222.66 Decreased By ▼ -10.63 (-4.56%)
PAEL 38.11 Increased By ▲ 2.99 (8.51%)
PIBTL 9.27 Decreased By ▼ -0.09 (-0.96%)
PPL 205.85 Decreased By ▼ -5.55 (-2.63%)
PRL 39.85 Increased By ▲ 3.33 (9.12%)
PTC 26.62 Increased By ▲ 0.58 (2.23%)
SEARL 110.24 Decreased By ▼ -4.56 (-3.97%)
TELE 9.23 Decreased By ▼ -0.18 (-1.91%)
TOMCL 38.21 Decreased By ▼ -0.39 (-1.01%)
TPLP 13.77 Increased By ▲ 0.98 (7.66%)
TREET 26.45 Increased By ▲ 0.47 (1.81%)
TRG 60.54 Decreased By ▼ -1.46 (-2.35%)
UNITY 34.14 Decreased By ▼ -1.43 (-4.02%)
WTL 1.88 Decreased By ▼ -0.04 (-2.08%)
BR100 12,299 Decreased By -48 (-0.39%)
BR30 38,877 Decreased By -222.6 (-0.57%)
KSE100 114,861 Decreased By -1308.7 (-1.13%)
KSE30 36,196 Decreased By -462.8 (-1.26%)

NEW YORK: Wall Street’s main indexes were flat to higher in choppy trading on Friday, with the Nasdaq reversing earlier losses as megacap tech stocks regained ground, while investors also assessed stronger-than-expected US business activity data.

Megacaps Microsoft Alphabet, Amazon.com and Apple rose between 0.7% and 2%, lifting the tech-heavy Nasdaq and helping the S&P 500 pare early losses.

The S&P 500 Technology index reversed early losses, rising 0.1%, while financial stocks were the biggest decliner.

All the three major Wall Street indexes were on track to post weekly gains, with the S&P 500 briefly crossing the 5,500-point milestone during Thursday’s session.

US business activity crept up to a 26-month high in June amid a rebound in employment, but price pressures subsided considerably, offering hope that a recent slowdown in inflation was likely to be sustained.

Flash services PMI increased to 55.1 this month, above expectations of 53.7, while manufacturing PMI edged up to 51.7, compared with expectations of a dip to 51.

May home sales fell to a seasonally adjusted annual rate of 4.11 million units versus expectations of 4.10 million units.

The market is also assessing a string of weakening economic data, and commentary from US Federal Reserve officials this week that interest rates could remain higher for longer if there is no consistent improvement in inflation numbers.

“It certainly looks like at this point the Fed is going to hold tight for a while ... the market is slowly adjusting to that reality,” said Lamar Villere, portfolio manager with Villere & Co.

Money markets are still pricing in a 58% chance of a 25-basis point rate cut in September, and still expect about two rate cuts this year, according to LSEG’s FedWatch data.

AI chip firm Nvidia slipped 0.5%, while semiconductor stocks Qualcomm, Broadcom and Micron Technology were down between 0.2% and 2%.

Wall Street’s bumper gains since the final leg of 2023 have been primarily driven by the likes of Nvidia and a handful of other heavily weighted stocks linked to artificial intelligence. Analysts, however, have raised concerns whether the strong increase in their valuations is sustainable.

Friday’s session will mark the expiry of quarterly derivatives contracts tied to stocks, index options and futures, also known as “triple witching”, adding to market volatility.

At 12:12 p.m. ET, the Dow Jones Industrial Average was down 9.57 points, or 0.02%, at 39,125.19, the S&P 500 was up 2.04 points, or 0.04%, at 5,475.21, and the Nasdaq Composite was up 45.86 points, or 0.26%, at 17,767.44.

Spirit AeroSystems rose 6.1% following a Reuters report that Boeing is nearing a deal to buy back the airplane parts supplier after months of talks.

Sarepta Therapeutics soared 35.2% after the US FDA allowed expanded use of the company’s gene therapy for patients with Duchenne muscular dystrophy aged four and older.

Comments

Comments are closed.